As Covid research heats up, J&J retires a BARDA-funded flu antiviral they worked on for 7 years

As Covid research heats up, J&J retires a BARDA-funded flu antiviral they worked on for 7 years

Source: 
Endpoints
snippet: 

The last eight months have seen a resurgence in antivirals as researchers, scrambling for something that might treat Covid-19, repurposed approved HIV drugs and racked the libraries of small molecules on pharma and biotech’s shelves for any that could inhibit the novel virus. But yesterday, J&J took an antiviral it had been testing for 7 years and formally put it back on the shelf.